Sophia Yui Kau Fong
Overview
Explore the profile of Sophia Yui Kau Fong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Lyu C, Fong S, Wang Q, Li C, Ho N, et al.
J Ethnopharmacol
. 2019 Jul;
243:112097.
PMID: 31325600
Ethnopharmacological Relevance: According to Traditional Chinese Medicine theory, influenza is categorized as a warm disease or Wen Bing. The Wen Bing formulas, such as Yin-Qiao-San and Sang-Ju-Yin, are still first-line...
2.
Fong S, Li C, Ho Y, Li R, Wang Q, Wong Y, et al.
Mol Pharm
. 2017 Apr;
14(9):2908-2916.
PMID: 28426226
Scutellariae Radix (SR) and its bioactive flavones elicit a variety of effects in the brain. However, the brain uptake of individual SR flavones and its relationship to the elicited effects...
3.
Fong S, Poulsen J, Brandl M, Bauer-Brandl A
Eur J Pharm Sci
. 2016 Sep;
96:154-163.
PMID: 27644896
A novel microdialysis-dissolution/permeation (M-D/P) system was developed for the biopharmaceutical assessment of oral drug formulations. This system consists of a side-by-side diffusion chamber, a microdialysis unit fixed within the dissolution...
4.
Fong S, Bauer-Brandl A, Brandl M
Expert Opin Drug Deliv
. 2016 Aug;
14(3):403-426.
PMID: 27488049
With the increasing number of poorly water-soluble compounds in drug discovery pipelines, supersaturating drug delivery systems (SDDS) have attracted increased attention as an effective bioavailability enhancing approach. However, a systematic...
5.
Fong S, Martins S, Brandl M, Bauer-Brandl A
J Pharm Sci
. 2016 Feb;
105(3):1113-23.
PMID: 26886329
Celecoxib (CXB) is a Biopharmaceutical Classification System class II drug in which its oral bioavailability is limited by poor aqueous solubility. Although a range of formulations aiming to increase the...
6.
Fong S, Ibisogly A, Bauer-Brandl A
Int J Pharm
. 2015 Oct;
496(2):382-91.
PMID: 26468038
The poor aqueous solubility of BCS Class II drugs represents a major challenge for oral dosage form development. Using celecoxib (CXB) as model drug, the current study adopted a novel...
7.
Fong S, Brandl M, Bauer-Brandl A
Eur J Pharm Sci
. 2015 Aug;
80:89-110.
PMID: 26296863
Low bioavailability nowadays often represents a challenge in oral dosage form development. Solid formulations composed of drug and phospholipid (PL), which, upon contact with water, eventually form multilamellar liposomes (i.e....
8.
Fong S, Zhang Y, Wong Y, Zhou L, Han Q, Zuo Z
Biopharm Drug Dispos
. 2015 Jun;
36(8):529-51.
PMID: 26109199
Mefenamic acid (MEF) is a widely prescribed non-steroidal anti-inflammatory drug that has been found associated with rare but severe cases of hepatotoxicity, nephrotoxicity and gastrointestinal toxicity. The formation of protein-reactive...
9.
Fong S, Wong Y, Xie C, Zuo Z
J Ethnopharmacol
. 2015 May;
170:106-16.
PMID: 25980420
Ethnopharmacological Relevance: Scutellariae Radix (SR), the dried root of Scutellariae baicalensis Georgi, has a lot in common with non-steroidal anti-inflammatory drugs (NSAIDs). Their similarities in therapeutic action (anti-inflammation) and metabolic...
10.
Fong S, Efferth T, Zuo Z
Expert Opin Drug Metab Toxicol
. 2014 Oct;
10(12):1711-39.
PMID: 25307559
Introduction: Concomitant use of NSAIDs and Chinese herbal medicines (CHMs) is frequent, yet summarized information on their interactions is lacking. Areas Covered: A systematic review of literature in four evidence-based...